Legal & General Group PLC Tg Therapeutics, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 168,718 shares of TGTX stock, worth $4.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,718

Previous 149,256 13.04%

Holding current value

$4.02 Million

Previous $2.27 Million 32.2%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $259,233 - $373,475	19,462 Added 13.04%	168,718 $3 Million
Q1 2024 May 14, 2024	BUY	$13.02 - $21.3 $28,097 - $45,965	2,158 Added 1.47%	149,256 $2.27 Million
Q4 2023 Feb 15, 2024	BUY	$6.68 - $18.81 $76,045 - $214,133	11,384 Added 8.39%	147,098 $2.51 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $19,353 - $61,347	2,315 Added 1.74%	135,714 $1.13 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $143,375 - $324,170	9,262 Added 7.46%	133,399 $3.31 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $103,169 - $195,043	10,085 Added 8.84%	124,137 $1.87 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $51,623 - $121,896	-10,304 Reduced 8.29%	114,052 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $75,976 - $139,650	-16,625 Reduced 11.79%	124,356 $736,000
Q2 2022 Aug 22, 2022	BUY	$3.74 - $10.66 $117,918 - $336,099	31,529 Added 28.81%	140,981 $599,000
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $632 - $1,656	81 Added 0.07%	109,452 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $4,985 - $11,647	328 Added 0.3%	109,371 $2.08 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $647,715 - $1.2 Million	29,739 Added 37.5%	109,043 $3.63 Million
Q2 2021 Aug 12, 2021	BUY	$32.5 - $48.96 $55,607 - $83,770	1,711 Added 2.21%	79,304 $3.08 Million
Q1 2021 May 17, 2021	BUY	$41.61 - $54.3 $110,058 - $143,623	2,645 Added 3.53%	77,593 $3.74 Million
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $340,892 - $740,601	13,490 Added 21.95%	74,948 $3.9 Million
Q3 2020 Nov 13, 2020	BUY	$18.49 - $27.24 $702,305 - $1.03 Million	37,983 Added 161.8%	61,458 $1.65 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $16,020 - $39,312	1,800 Added 8.3%	23,475 $457,000
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $26,303 - $58,907	-3,684 Reduced 14.53%	21,675 $213,000
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $21,435 - $47,073	4,203 Added 19.87%	25,359 $281,000
Q3 2019 Nov 13, 2019	BUY	$5.38 - $8.99 $18,690 - $31,231	3,474 Added 19.65%	21,156 $119,000
Q2 2019 Aug 14, 2019	BUY	$6.27 - $8.65 $47,006 - $64,849	7,497 Added 73.61%	17,682 $153,000
Q3 2018 Nov 20, 2018	BUY	$5.15 - $14.0 $4,604 - $12,516	894 Added 9.62%	10,185 $57,000
Q2 2018 Aug 10, 2018	SELL	$12.5 - $15.0 $3,437 - $4,125	-275 Reduced 2.87%	9,291 $122,000
Q1 2018 May 17, 2018	SELL	$8.7 - $16.8 $34,739 - $67,082	-3,993 Reduced 29.45%	9,566 $136,000
Q4 2017 Feb 13, 2018	BUY	$7.35 - $12.3 $99,658 - $166,775	13,559	13,559 $114,000

Others Institutions Holding TGTX

# of Institutions

287

Shares Held

91.8M

Call Options Held

1.9M

Put Options Held

1.45M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.46B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Tg Therapeutics, Inc. Transaction History